U. Börjesson
发表
P. Hünenberger,
U. Börjesson,
2001
.
S. Tentarelli,
M. Vázquez‐Chantada,
E. Chiarparin,
2021,
Journal of medicinal chemistry.
U. Börjesson,
C. Tyrchan,
M. Perry,
2022,
Bioorganic & medicinal chemistry letters.
C. Stubbs,
I. Dale,
U. Börjesson,
2020,
ACS medicinal chemistry letters.
Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition
D. M. Smith,
David M. Smith,
N. Selmi,
2020,
Cell Death Discovery.
R. Lewis,
U. Börjesson,
Magnus Nilsson,
2021,
ACS medicinal chemistry letters.
N. Blomberg,
O. Engkvist,
U. Börjesson,
2009
.
R. Jetson,
C. Stubbs,
I. Dale,
2022,
Bioorganic & medicinal chemistry letters.
Roger A. Nadeau,
Jonathan B Sumner,
T. Furukawa,
2022,
Clinical Research in Cardiology.
J. Riddell,
B. Hudson,
A. Tobin,
2022,
eLife.
Paul Harper,
Louise Ford,
John Archer,
2019,
Nature Communications.
J. Riddell,
B. Hudson,
G. Milligan,
2020,
bioRxiv.
J A McCammon,
J. Mccammon,
M. Philippopoulos,
2001,
Biophysical journal.
H. Lindmark,
U. Börjesson,
C. Tyrchan,
2021,
Journal of medicinal chemistry.
P. Hünenberger,
U. Börjesson,
2003,
Protein engineering.
C. Stubbs,
I. Dale,
U. Börjesson,
2020,
ACS medicinal chemistry letters.
E. Hennessy,
T. Moss,
C. Stubbs,
2023,
Journal of medicinal chemistry.
Pedro F. Campos,
Roger A. Nadeau,
Jonathan B Sumner,
2021,
BMJ.
Roger A. Nadeau,
Jonathan B Sumner,
T. Furukawa,
2022,
Clinical Research in Cardiology.
U. Börjesson,
C. Tyrchan,
M. Perry,
2022,
Bioorganic & medicinal chemistry letters.
Anthony D. Keefe,
Nancy Su,
N. Selmi,
2024,
ACS Medicinal Chemistry Letters.